Why is Alembic Pharma falling/rising?

As of 01-Jul, Alembic Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 1,014.60, which reflects a decrease of 28.0 points or 2.69%. Today's price summary indicates that the stock has underperformed its sector by 2.48% and has fallen after five consecutive days of gains. The stock touched an intraday low of Rs 1002.05, marking a 3.89% drop. Despite this decline, Alembic Pharma is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a generally positive trend prior to this drop. Over the past year, the stock has generated a return of 9.82%, although profits have decreased by 7%. The company maintains a strong ability to service debt with a low Debt to EBITDA ratio of 0.67 times and has high institutional holdings at 20.37%, indicating confidence from larger investors.
In the broader market context, Alembic Pharmaceuticals' short-term performance over the past week shows a gain of 7.57%, which is significantly higher than the Sensex's increase of 2.00%. However, the stock's year-to-date performance is down by 4.21%, contrasting with the Sensex's rise of 7.11%. This disparity highlights the stock's recent struggles despite some positive long-term returns, as it trades at a discount compared to its peers' average historical valuations. The increase in delivery volume by 3257.21% against the 5-day average suggests rising investor participation, yet the current price movement indicates a cautious sentiment among investors following the recent decline.